Discover
ANAB
AnaptysBio, Inc.
45.59
2 x 32.76
2 x 58.54
bid
ask
-
0.45
0.98%
2 @ 05:12 AM
45.59 +0.00 (0.00%)
| Ytd | 41.06% | |
| 1y | 110.67% |
45.16
day range
46.13
20.18
52 week range
72.36
| Open | 45.53 | Prev Close | 46.04 | Low | 45.16 | High | 46.13 | Mkt Cap | 1.36B |
| Vol | 416.53K | Avg Vol | 558.97K | EPS | -0.96 | P/E | N/A | Forward P/E | 9.00 |
| Beta | 0.76 | Short Ratio | 8.96 | Inst. Own | 105.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 54.19 | 200-d Avg | 49.24 | 1yr Est | 87.25 |
ANAB News
benzinga.com
JP Morgan Maintains Overweight on AnaptysBio, Lowers Price Target to $60
JP Morgan analyst Anupam Rama maintains AnaptysBio (NASDAQ:ANAB) with a Overweight and lowers the
benzinga.com
HC Wainwright & Co. Reiterates Buy on AnaptysBio, Maintains $95 Price Target
HC Wainwright & Co. analyst Joseph Pantginis reiterates AnaptysBio (NASDAQ:ANAB) with a Buy a
benzinga.com
Leerink Partners Maintains Outperform on AnaptysBio, Lowers Price Target to $81
Leerink Partners analyst David Risinger maintains AnaptysBio (NASDAQ:ANAB) with a Outperform and
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's
benzinga.com
AnaptysBio Q2 Adj. EPS $(0.11) Beats $(0.46) Estimate, Sales $27.488M Beat $21.675M Estimate
AnaptysBio (NASDAQ:ANAB) reported quarterly losses of $(0.11) per share which beat the analyst conse